The Austedo approval is notable for two reasons: One, it is the first deuterated drug (i.e., a drug containing the stable isotope — deuterium — in place of a hydrogen atom) to be approved by ...
The global deuterated drugs market, valued at US$ 334.0 million in 2023, presents a robust growth pattern. With a projected valuation of US$ 871.8 million by 2032 at a CAGR of 11.25%, the market is ...
Discover Sun Pharmaceutical's new patent for synthesizing D-serine-2-d, detailing innovative methods and versatile compounds for advanced pharmaceutical applications.
"We are making rapid advancements in our two lead clinical programs – CYB003, our proprietary deuterated psilocin program in development for the adjunctive treatment of Major Depressive Disorder ...
We have two assets in the clinic at the moment. Our CYB003 program, which is a deuterated psilocin, has completed Phase 2. We have some really spectacular Phase 2 results that I'd be happy to ...
Cybin has strengthened its clinical and R&D team with the recent addition of senior team members: Dr. Mirza Rahman, M.D., M.P.H., FACPM, Senior Vice President, Patient Safety & Pharmacovigilance. Dr.
Intra-Cellular ITCI is focused on discovering, developing and commercializing small molecule drugs for treating neuropsychiatric and neurological disorders. The company currently has only one marketed ...